| Literature DB >> 9757054 |
K Gerber1, J Filakovszky, P Halasz, G Bagdy.
Abstract
The effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) on the epileptiform activity has been investigated in adult WAG/RIJ rats. Either intraperitoneal (0.1-0.5 mg/kg) or intracerebroventricular (2-20 microg/rat) administration of 8-OH-DPAT caused marked, dose-dependent increases in the number and mean cumulative duration of spike-wave discharges. These effects were attenuated by NAN-190, a 5-HT1A receptor antagonist. These data indicate that serotonergic system regulates the epileptiform activity in this genetic model of human absence epilepsy. Copyright 1998 Elsevier Science B.V.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9757054 DOI: 10.1016/s0006-8993(98)00801-4
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252